Health Care Delivery

Latest News


CME Content


This week, the top managed care news included President Trump issuing an executive order for more healthcare transparency; provisional data indicating that overdose deaths may be falling; the Supreme Court agreeing to hear insurers' Affordable Care Act lawsuit.

The US Supreme Court will decide a case involving 2 insurance companies that claimed they were shorted $12 billion by the federal government for "risk corridor" payments related to the ACA; Missouri's last abortion clinic will stay open until at least Friday after a state circuit court judge extended a preliminary injunction he previously issued; City of Hope will invest $1 billion in a new cancer research center and hospital in Irvine, California.

In a letter to CMS Administrator Seema Verma, Energy and Commerce Committee Chairman Frank Pallone Jr, D-New Jersey, and Ways and Means Committee Chairman Richard E. Neal, D-Massachusetts, have demanded information on the Trump administration’s changes to the federal marketplace, which they say can cause confusion for enrollees, weaken consumer protections, and further compromise the Affordable Care Act (ACA).

A study found that out of hundreds of specialty drugs, only 16% were covered in the same way by 17 commercial payers in the United States, meaning that 84% of those specialty drugs had differing coverage, explained James D. Chambers, PhD, MPharm, MSc, associate professor, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center.

HHS Secretary Alex Azar and Attorney General Bill Barr opposed the Trump administration’s support to overturn the Affordable Care Act (ACA) through a federal lawsuit; OxyContin maker Purdue Pharma and its owners, the Sackler family, agreed to pay $270 million to avoid a state court trial in Oklahoma over the company’s role in the spread of opioids over the past 20 years; a New York county is banning unvaccinated children in public places in the wake of a measles crisis that has infected more than 150 people.

The March issue of The American Journal of Managed Care® (AJMC®) featured research on immuno-oncology costs and Medicare Annual Wellness Visits in addition to studies on the issue’s theme of Medicaid. Here are 5 findings from research published in the issue.

“Medicare for Al” refers to a bill originally introduced to Congress in September 2017 by Senator Bernie Sanders, I-Vermont, with 16 Democratic cosponsors that would create a single, federal, government-administered program to provide healthcare to all US residents. In February 2019, Representative Pramila Jayapal, D-Washington, introduced the Medicare for All Act of 2019, with 106 cosponsors. This bill builds upon the legislation that Sanders introduced, with a few key differences. Here are 5 things to know about the bills.

Drug use is fueling record-high syphilis rates around the nation, a CDC report said; the Fifth Circuit Court of Appeals is allowing House Democrats to defend the Affordable Care Act (ACA) in a lawsuit that challenges the law’s constitutionality; the World Health Organization (WHO) is convening an expert meeting in March to develop global standards for the governance and oversight of human gene editing.

A new report from the Commonwealth Fund looking at healthcare coverage said the uninsured rate is basically unchanged from before President Trump took office, but that more people, primarily those who have coverage through work, are underinsured. By late fall of 2018, 12.4% of adults were uninsured, down from a high of 20% before the Affordable Care Act became law.

Voters in the red states of Utah and Idaho voted to expand Medicaid under the Affordable Care Act last fall, but Republican legislatures in both those states are seeking ways to roll back those expansions; women sought out long-acting reversible contraception after the election of President Trump; a California coalition of health, labor, and education leaders cited a dearth of healthcare workers in recommending a workforce investment plan calling for spending up to $3 billion over 10 years to address the shortfall.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo